甲胺:抑制细胞核转移,对抗癌症和衰老
Jorge Iván Castillo-Quan1, T Keith Blackwell1
1Research Division, Joslin Diabetes Center, Boston, MA 02215, USA; Department of Genetics and Harvard Stem Cell Institute, Harvard Medical School, Boston MA 02115, USA.
Cell
|December 17, 2016
概括
甲胺通过激活ACAD10延长寿命并抑制生长. 这通过一种新的途径发生,其中甲素导致GTPase RagC从细胞核中被排除,从而抑制mTORC1.
科学领域:
- 细胞生物学
- 遗传学
- 代谢过程
背景情况:
- 甲胺是一种广泛用于治疗2型糖尿病的药物.
- 它对衰老和生长的影响尚未完全理解.
- 拉巴胺素复合物1 (mTORC1) 途径的机理性标对细胞生长和新陈代谢至关重要.
研究的目的:
- 阐明甲胺影响寿命和生长的分子机制.
- 确定甲胺作用中的关键分子.
主要方法:
- 实验使用模型生物C. elegans进行.
- 人类细胞系被用于体外研究.
- 研究了GTPase RagC和转录标ACAD10的作用.
主要成果:
- 甲胺治疗导致GTPase RagC的核排除.
- 这种核排除导致了ACAD10的激活.
- 发现ACAD10激活可以抑制mTORC1通路.
结论:
- 发现了一种新的途径,将甲素与寿命延长和生长抑制联系起来.
- 该机制涉及通过RagC核排斥和随后的mTORC1抑制调节ACAD10.
相关概念视频
Oral Hypoglycemic Agents: Biguanides and Glitazones
771
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
771
mTOR Signaling and Cancer Progression
5.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
5.0K
Electron Transport Chain: Complex I and II
19.3K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
19.3K
Drugs that Stabilize Microtubules
2.8K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.8K
Inhibition of Cdk Activity
6.1K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Replicative Cell Senescence
4.5K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
4.5K


